Sino Biological 新冠病毒 Spike 兔多抗 WB/ELISA

1, Prahlad J, et al. CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domain.Protein science : a publication of the Protein Society, PubMed ID: 34191362
2, He X, et al. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.Emerging microbes & infections, PubMed ID: 34304724
3, Zhang Y, et al. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.Cell chemical biology, PubMed ID: 34672954
4, Ohtsuka J, et al. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2.iScience, PubMed ID: 34805782
5, Wang Q, et al. iScience, PubMed ID: 34746689
6, Cao K, et al. A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.Journal of virology, PubMed ID: 34908443
7, Shao L, et al. The large nonstructural protein (NS1) of the human bocavirus 1 (HBoV1) directly interacts with Ku70, which plays an important role in virus replication in human airway epithelia.Journal of virology, PubMed ID: 34878919
8, Haga K, et al. Luciferase-based quantification of membrane fusion induced by SARS-CoV-2 S protein.Genes to cells : devoted to molecular & cellular mechanisms, PubMed ID: 35488742
9, Frolova EI, et al. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.Journal of virology, PubMed ID: 35876526
10, Lubinski B, et al. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.Microbiology spectrum, PubMed ID: 35766497
11, Cooper A, et al. A genetically engineered, stem-cell-derived cellular vaccine.Cell reports. Medicine, PubMed ID: 36480934
12, Seo SE, et al. Fluorophore-encapsulated nanobeads for on-site, rapid, and sensitive lateral flow assay.Sensors and actuators. B, Chemical, PubMed ID: 36684645
13, Chen K, et al. Adenovirus Vaccine Containing Truncated SARS-CoV-2 Spike Protein S1 Subunit Leads to a Specific Immune Response in Mice.Vaccines, PubMed ID: 36851306
14, Qu P, et al. Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants.bioRxiv : the preprint server for biology, PubMed ID: 36711991
15, Dong W, et al. Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection.Nature communications, PubMed ID: 37024459
16, Yurkovetskiy L, et al. S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness.bioRxiv : the preprint server for biology, PubMed ID: 37034621
17, Wu X, et al. Optimization and Deoptimization of Codons in SARS-CoV-2 and Related Implications for Vaccine Development.Advanced science (Weinheim, Baden-Wurttemberg, Germany), PubMed ID: 37267926
18, Qu P, et al. Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants.bioRxiv : the preprint server for biology, PubMed ID: 37745517
19, Liu L, et al. Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking.Immunity, PubMed ID: 37776849
20, Kim D, et al. Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2.Frontiers in cellular and infection microbiology, PubMed ID: 38029235
21, Guimaraes LC, et al. Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models.Nature communications, PubMed ID: 38238326
22, Kim D, et al. A mouse xenograft long-term replication yields a SARS-CoV-2 Delta mutant with increased lethality.Journal of medical virology, PubMed ID: 38345153
23, Deng J, et al. Natural evidence of coronaviral 2'-O-methyltransferase activity affecting viral pathogenesis via improved substrate RNA binding.Signal transduction and targeted therapy, PubMed ID: 38811528
24, Hong W, et al. A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants.MedComm, PubMed ID: 38680520
25, Emam MH, et al. Establishment of in-house assay for screening of anti-SARS-CoV-2 protein inhibitors.AMB Express, PubMed ID: 39285019